Related coverage linked through entity extraction aliases.
Feb 20, 2026
The FDA has approved the combination of Venclexta (venetoclax) plus acalabrutinib as the first all-oral, fixed-duration regimen for previously untreated adults with chronic lymphocytic leukemia, based on Phase III AMPLIFY study results.
Feb 18, 2026
The FDA agreed to review Moderna's mRNA-based flu vaccine after initially rejecting the application, following a Type A meeting that led to a revised regulatory approach splitting approval pathways by age group.
Feb 13, 2026
Research published in the New England Journal of Medicine reveals that while 43% of healthcare organizations are piloting agentic AI, only 3% have deployed it in live workflows, with 60% of executives believing it will transform patient-provider experiences.
